A med spa should write about its treatments with the care of a medical practice: state each product's FDA status and approved use exactly, say who performs and supervises each treatment under the state rules that apply, and describe the consultation rather than the result. The FTC judges an ad by its overall impression, including images and product names, so the treatment menu, the specials page, and the social feed all count. State rules on who may perform treatments vary, so those answers come from counsel.
Med spa marketing often borrows its language from the spa side of the business: relaxing, lunchtime, glow. The treatments on the menu can involve prescription drugs, regulated devices, and licensed clinicians. The gap between that tone and that substance is where advertising questions tend to start.
This is a content and marketing article for med spa owners and marketing leads. It is not legal advice and not guidance on any treatment. The general approach to procedure pages, including before and after images, is in treatment pages that explain care without promising outcomes.
Read the page the way the FTC does
The FTC's Health Products Compliance Guidance says "FTC advertising law applies to all products and claims," and tells advertisers to consider the "net impression" conveyed by all elements of an ad. It names "the text, product name, and any charts, graphs, and other images" as part of what an ad says. A treatment page that never states a result in words can still imply one through a headline image, a product name, and a countdown timer on a discount.
The same guidance says that when a disclosure is needed to prevent deception, "advertisers should present the information clearly and conspicuously," and it treats fine print at the bottom of an ad as falling short of that. A footnote is not a fix. If a statement needs a condition, the condition belongs in the same sentence.
Describe FDA status exactly
Product status is an easy place for med spa copy to overreach. The FTC guidance says "Advertisers should be careful not to mischaracterize the extent to which a product or claim has been reviewed, authorized, or approved by the FDA." One of its examples involves an electronic belt that had FDA clearance as a Class II medical device, promoted in an infomercial that repeated "FDA Approved" next to weight-loss claims. The FTC calls that deceptive because the pairing "gives the impression that the FDA has found the product to be effective" for those effects.
The lesson for a treatment menu is that a product's FDA status says nothing about results on its own, and putting the two side by side can make it seem to. Before the page goes to review, put this to the medical director for each product: "What exactly did FDA approve or clear, and for which use?" Then use that exact language, taken from the FDA record or the product's labeling, and keep result language out of the same sentence.
Approved uses matter as well. FDA's page on dermal fillers (content current as of July 2023) says "The FDA has approved dermal fillers for use in adults 22 years of age or older," and of certain other uses, including breast augmentation and buttock enlargement, it says "These uses for dermal fillers are not approved by the FDA." The same page says "Having filler injected should be considered a medical procedure, not a cosmetic treatment." Copy that presents an injectable as a casual add-on sits awkwardly beside that statement. Whether and how to mention a use outside a product's approved indications is a question for counsel.
Say who performs the treatment, by role
Patients ask who will be holding the syringe or the device, and the answer depends on state law. Rules on which licensed professionals may perform, delegate, and supervise aesthetic treatments vary by state and can differ by treatment type. Do not borrow another state's rule, a franchisor's template, or a training company's summary.
Write the answer as the practice's confirmed facts: the role and license of the person who performs each treatment, who supervises, and whether a medical professional evaluates the patient before the first treatment. The writer should not have to work out delegation rules from a vendor's brochure; the medical director and counsel confirm them, and the page states the result. A phrase such as "our expert injectors" gives a patient nothing to check, while a named provider with a linked bio does.
Specials, packages, and the consultation
Promotions are part of the ad too. A package price or a first-treatment discount can suggest that the treatment and the amount are settled before anyone has been evaluated. A menu price is not a treatment plan. If the practice requires a consultation before treatment, the specials page should say so next to the price, and the price should name what it covers.
Keep the specials page, the treatment page, and the social posts telling the same story. A careful treatment page undercut by a story post that says "no downtime, book now" is still the practice making that claim.
A fictional claims check
Here is a hypothetical review of draft copy for a fictional med spa in Florida. It shows how to flag lines for review, not what any product does or what Florida requires.
| Draft line | What to flag | Who resolves it |
|---|---|---|
| "FDA-approved for every area of the face" | FDA status and approved uses of the specific product | Medical director, from the labeling |
| "Lunchtime treatment, back to work right away" | Recovery described in absolute terms | Supervising clinician |
| "Performed by our expert injectors" | Role, license, and supervision not stated | Medical director and counsel |
| "Results last up to two years" | Duration claim needing support for this product and use | Medical director, from labeling and evidence |
| "This month only: a discount on your first treatment" | Implies treatment before evaluation | Practice manager, adding the consultation step |
None of these lines is unusual. Each one needs an answer from someone other than the writer before it can stay.
In Hudson South's process, the Authority Asset gathers each product's confirmed status, the practice's role and supervision facts, and the evidence behind any claim; Hudson Twenty-One records how the practice's clinicians communicate across 21 dimensions; Market Intelligence researches what prospective patients ask before booking; and AEO Creation turns those inputs into answer-first content. Clinical sign-off still belongs to the practice, as set out in clinical review for health content. For more on aesthetic practices, see content for med spas and the guide to content for medical, dental and wellness practices.
Compare your treatment pages with nearby med spas
On a free 30-minute call, Hudson South walks you through the gaps between your website and the practices your patients compare you with.
Get your free competitor analysisSources
- Health Products Compliance Guidance. Federal Trade Commission. Read 2026-10-15.
- Dermal Fillers (Soft Tissue Fillers). U.S. Food and Drug Administration. Read 2026-10-15.